Literature DB >> 12682776

Positional cloning of jcpk/bpk locus of the mouse.

Cathy Cogswell1, Sarah J Price, Xiaoying Hou, Lisa M Guay-Woodford, Lorraine Flaherty, Elizabeth C Bryda.   

Abstract

By positional cloning techniques, we have identified the gene that is disrupted in the jcpk and bpk mouse models for polycystic kidney disease. This gene is the mouse homolog of the Drosophila Bicaudal C gene. Both of these mutations have been mapped to a very short stretch of Chromosome (Chr) 10. By sequencing the bicaudal C gene, Bicc1, in these models, it was found that the jcpk mutation results in a shortened and abnormal transcript, whereas the bpk mutation results in an abnormal 3' coding region. In Drosophila, this gene encodes a protein known to influence developmental processes. The mammalian homolog contains three KH (K homology) domains and a SAM (sterile alpha motif) domain and is expressed in the developing embryo, indicating that it may be important in RNA-binding and/or protein interactions during embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682776     DOI: 10.1007/s00335-002-2241-0

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  40 in total

1.  Polycystin-1 regulates STAT activity by a dual mechanism.

Authors:  Jeffrey J Talbot; Jonathan M Shillingford; Shivakumar Vasanth; Nicholas Doerr; Sambuddho Mukherjee; Mike T Kinter; Terry Watnick; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.

Authors:  Zakir Hossain; Safiah Mohamed Ali; Hui Ling Ko; Jianliang Xu; Chee Peng Ng; Ke Guo; Zeng Qi; Sathivel Ponniah; Wanjin Hong; Walter Hunziker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

Review 3.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.

Authors:  Margaret Daniele Fallin; Megan Szymanski; Ruihua Wang; Adrian Gherman; Susan S Bassett; Dimitrios Avramopoulos
Journal:  Neurogenetics       Date:  2010-02-25       Impact factor: 2.660

5.  The SAM domain of ANKS6 has different interacting partners and mutations can induce different cystic phenotypes.

Authors:  Zeineb Bakey; Marie-Thérèse Bihoreau; Rémi Piedagnel; Laure Delestré; Catherine Arnould; Alexandre d'Hotman de Villiers; Olivier Devuyst; Sigrid Hoffmann; Pierre Ronco; Dominique Gauguier; Brigitte Lelongt
Journal:  Kidney Int       Date:  2015-06-03       Impact factor: 10.612

6.  Disease Modeling To Understand the Pathomechanisms of Human Genetic Kidney Disorders.

Authors:  Elisa Molinari; John A Sayer
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-05       Impact factor: 8.237

7.  Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease.

Authors:  Erin E Olsan; Jonathan D West; Jacob A Torres; Nicholas Doerr; Thomas Weimbs
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-07

8.  The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity.

Authors:  Uyen Tran; Lise Zakin; Axel Schweickert; Raman Agrawal; Remziye Döger; Martin Blum; E M De Robertis; Oliver Wessely
Journal:  Development       Date:  2010-04       Impact factor: 6.868

9.  Src inhibition ameliorates polycystic kidney disease.

Authors:  William E Sweeney; Rodo O von Vigier; Philip Frost; Ellis D Avner
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

10.  Autosomal recessive polycystic kidney disease epithelial cell model reveals multiple basolateral epidermal growth factor receptor sorting pathways.

Authors:  Sean Ryan; Susamma Verghese; Nicholas L Cianciola; Calvin U Cotton; Cathleen R Carlin
Journal:  Mol Biol Cell       Date:  2010-06-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.